Record Display for the EPA National Library Catalog

RECORD NUMBER: 1 OF 11

OLS Field Name OLS Field Data
Main Title An introduction to pharmacovigilance /
Author Waller, Patrick,
Other Authors
Author Title of a Work
Harrison-Woolrych, Mira,
Publisher Wiley Blackwell/John Wiley & Sons Inc.,
Year Published 2017
OCLC Number 965761377
ISBN 9781119289746; 1119289742
Subjects Drugs--Side effects. ; Pharmacoepidemiology. ; Pharmacovigilance. ; Drug Monitoring--methods. ; Drug-Related Side Effects and Adverse Reactions. ; Pharmaceutical Preparations--standards.
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
ELBM  RM302.5.W35 2017 AWBERC Library/Cincinnati,OH 12/12/2018
Edition Second edition.
Collation xix, 170 pages : illustrations ; 22 cm
Notes
Includes bibliographical references. "This new edition of a clear and succinct yet comprehensive guide to the field provides exactly the right introduction for those new to the challenges and the excitement of pharmacovigilance. It conveys the importance to public health protection of an effective safety net to pick up new information, and the need for well-planned strategies to generate new evidence as an enabler of innovation"--Foreword. Mira Harrison-Woolrych is a New Zealand author.
Contents Notes
What is pharmacovigilance and how has it developed? -- Basic concepts -- Types and sources of data -- The process of pharmacovigilance -- Regulatory aspects of pharmacovigilance -- International collaboration -- Clinical aspects of adverse drug reactions -- Ethical and societal considerations -- Future directions -- Learning more about pharmacovigilance. Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance.